FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

E Brand

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Procedures

Disorders

Actinobacillus Infections

Phenomena

Bacteriolysis

Co-author Network

Publications

TOP 3
V Huter; Andreas Hensel; E Brand; Werner Lubitz
Improved protection against lung colonization by Actinobacillus pleuropneumoniae ghosts: characterization of a genetically inactivated vaccine.
Andreas Hensel; V Huter; A Katinger; P Raza; C Strnistschie; Uwe Roesler; E Brand; Werner Lubitz
Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.
Werner Lubitz; Angela Witte; Francis O Eko; M Kamal; Wolfgang Jechlinger; E Brand; J Marchart; Wolfgang Haidinger; V Huter; Diana Felnerova; N Stralis-Alves; S Lechleitner; Helen Melzer; Michael Szostak; Stephanie Resch; HJ Mader; B Kuen; Burkhard Mayr; Peter Mayrhofer; R Geretschläger; Alexander G Haslberger; Andreas Hensel
Extended recombinant bacterial ghost system.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of E Brand (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: V Huter; Andreas Hensel; E Brand; Werner Lubitz
Improved protection against lung colonization by Actinobacillus pleuropneumoniae ghosts: characterization of a genetically inactivated vaccine.
Journal of biotechnology 2000;83(1-2):161-72.
2000: Andreas Hensel; V Huter; A Katinger; P Raza; C Strnistschie; Uwe Roesler; E Brand; Werner Lubitz
Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.
Vaccine 2000;18(26):2945-55.
1999: Werner Lubitz; Angela Witte; Francis O Eko; M Kamal; Wolfgang Jechlinger; E Brand; J Marchart; Wolfgang Haidinger; V Huter; Diana Felnerova; N Stralis-Alves; S Lechleitner; Helen Melzer; Michael Szostak; Stephanie Resch; HJ Mader; B Kuen; Burkhard Mayr; Peter Mayrhofer; R Geretschläger; Alexander G Haslberger; Andreas Hensel
Extended recombinant bacterial ghost system.
Journal of biotechnology 1999;73(2-3):261-73.
1999: Francis O Eko; Angela Witte; V Huter; B Kuen; S Fürst-Ladani; Alexander G Haslberger; A Katinger; Andreas Hensel; Michael Szostak; Stephanie Resch; HJ Mader; P Raza; E Brand; J Marchart; Wolfgang Jechlinger; Wolfgang Haidinger; Werner Lubitz
New strategies for combination vaccines based on the extended recombinant bacterial ghost system.
Vaccine 1999;17(13-14):1643-9.
1998: Angela Witte; E Brand; Peter Mayrhofer; F Narendja; Werner Lubitz
Mutations in cell division proteins FtsZ and FtsA inhibit phiX174 protein-E-mediated lysis of Escherichia coli.
Archives of microbiology 1998;170(4):259-68.
1997: Michael Szostak; HJ Mader; Michael Truppe; M Kamal; Francis O Eko; V Huter; J Marchart; Wolfgang Jechlinger; Wolfgang Haidinger; E Brand; Ewald denner; Stephanie Resch; E Dehlin; A Katinger; B Kuen; Alexander G Haslberger; Andreas Hensel; Werner Lubitz
Bacterial ghosts as multifunctional vaccine particles.
Behring Institute Mitteilungen 1997;(98):191-6.